SCHEMBL26847368

SCHEMBL26847368

C=C1NC(c2cncc(CSc3[nH]c(=O)cc(-c4ccccc4)c3C#N)c2)=NO1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 3/20 0.36
▸ ACMSD Q8TDX5 3/20 0.35
▸ KMT2A Q03164 10/20 0.34
▸ HPGD P15428 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ ATM Q13315 1/20 0.34
▸ MEN1 O00255 9/20 0.33
▸ POLB P06746 6/20 0.33
▸ TNF P01375 2/20 0.33
▸ NOD2 Q9HC29 2/20 0.33
▸ NOD1 Q9Y239 2/20 0.33
▸ PLA2G1B P04054 1/20 0.33
▸ ATG4B Q9Y4P1 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ ADORA2B P29275 1/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ HSD11B2 P80365 1/20 0.33
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26847367 0.90 KMT2A (0.40) HSD11B1ACMSDKMT2AHPGDALDH1A1
SCHEMBL26847371 0.88 KDM4E (0.39) ACMSDKMT2AHPGDALDH1A1MEN1
SCHEMBL26847313 0.83 ACMSD (0.32) ACMSDKMT2AMEN1POLBCYP2C19
SCHEMBL26847307 0.81 KMT2A (0.39) HSD11B1ACMSDKMT2AHPGDALDH1A1
SCHEMBL24087895 0.79 ACMSD (0.45) HSD11B1ACMSDKMT2AHPGDALDH1A1
SCHEMBL26847363 0.79 ACMSD (0.45) ACMSDKMT2AHPGDALDH1A1MEN1
SCHEMBL20340157 0.78 ACMSD (0.51) HSD11B1ACMSDKMT2AHPGDALDH1A1
SCHEMBL31443033 0.78 ACMSD (0.51) HSD11B1ACMSDKMT2AHPGDALDH1A1
SCHEMBL20339841 0.76 KMT2A (0.54) ACMSDKMT2AHPGDALDH1A1MEN1
SCHEMBL26847309 0.74 ACMSD (0.39) HSD11B1ACMSDKMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 HSD11B1 1734/4885ACMSD 1/4885KMT2A 1353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback